We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Exaeris and Accentia Ink Deal For Turbo Dose-Counting Device
Exaeris and Accentia Ink Deal For Turbo Dose-Counting Device
May 10, 2006
Exaeris, a subsidiary of Inyx, and TEAMM Pharmaceuticals, the specialty pharmaceutical division of Accentia, announced April 13 they have finalized an agreement to co-market the MD Turbo.